Supported by

Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

422 results

Operator volumes and in-hospital outcomes: an analysis of 7,740 rotational atherectomy procedures from the BCIS national database

05 Jul 2021

Find out more about the results of this analysis which suggest that operator experience may be an important effect modifier in ROTA-PCI.

Nicola Ryan

Reviewer

Nicola Ryan
Operator volumes and in-hospital outcomes: an analysis of 7,740 rotational atherectomy procedures from the BCIS national database

A step-by-step protected high-risk PCI with the Impella CP

06 Jul 2021

Find out more about the case of an 85-year-old male with dyslipidemia, former smoker with previous cardiovascular events, symptomatic for worsening epigastric pain and shortness of breath...

Gabriele Pesarini

Author

Gabriele Pesarini

Author

Flavio Luciano Ribichini
A step-by-step protected high-risk PCI with the Impella CP

EBC MAIN Late-breaking trial analysis

13 Jun 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability of the EBC MAIN trial presented at EuroPCR 2021.

EBC MAIN Late-breaking trial analysis

EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in bifurcation lesions:

  • EBC MAIN - the European Bifurcation Club Left Main Coronary Bifurcation Study
  • Clinical Outcomes after Physiology-Guided Treatment of Coronary Bifurcations
EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!

Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease

20 May 2021 – From EuroPCR 2021

Watch this session presented by Sukhjinder Nijjer, Nick Curzen, Rasha Al-Lamee and Sayan Sen in order to learn about the new pressure guide wire OmniWire and workflow enhancement with Azurion and IntraSight, to understand how "interventional physiology" can guide PCI in diffuse, multivessel coronary artery disease, and to learn how...

Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease

Sustained Limus release, redefining indications for drug-eluting balloons

20 May 2021 – From EuroPCR 2021

Watch this session presented by Bernardo Cortese, Kambis Mashayekhi, Jonas Häner and Tuomas Rissanen in order to understand how sustained Limus release technology can broaden DEB indications, to learn how SELUTION SLR sustained Limus DEB performs in daily clinical practice, and to know more about the importance of sustained Limus release technology...

Sustained Limus release, redefining indications for drug-eluting balloons

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 1)

19 May 2021 – From EuroPCR 2021

Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 1)

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 2)

19 May 2021 – From EuroPCR 2021

Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 2)

A case-based approach: finding balance between bleeding and ischemic risk

19 May 2021 – From EuroPCR 2021

Watch this session presented by David Kandzari, Mirvat Alasnag, Emmanouil Brilakis, Chorcheung Frankie Tam and Beatriz Vaquerizo in order to debate case complexity of patient characteristics and complex lesions in HBR patients, to review patient centered clinical judgment and individualised treatment plans, and to analyse current Onyx ONE...

A case-based approach: finding balance between bleeding and ischemic risk

Multivessel disease revascularisation: balancing the risk

19 May 2021 – From EuroPCR 2021

Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...

Multivessel disease revascularisation: balancing the risk